Recombinant Human SLC16A4 Protein ，His

SLC16A4, also known as the Sodium-Coupled Monocarboxylate Transporter 4 (MCT4), plays a crucial role in the transport of lactate and other monocarboxylates across cellular membranes, facilitating energy metabolism and maintaining pH balance in tissues such as muscle and brain. The importance of SLC16A4 in cellular processes has garnered significant interest, particularly in the context of various physiological and pathological conditions, including exercise physiology, cancer, and neurodegenerative diseases. Research has shown that altered expression of SLC16A4 can affect lactate clearance and overall metabolic homeostasis, implicating it in the development of metabolic disorders. Additionally, SLC16A4's involvement in the export of lactate during glycolytic activity in tumors makes it a potential therapeutic target for cancer treatments aimed at reprogramming tumor metabolism. The generation of recombinant SLC16A4 protein has become essential for understanding its structure-function relationships, developing pharmacological agents, and exploring therapeutic interventions. By studying this protein in vitro and in vivo, researchers aim to unravel its mechanisms of action and determine its role in various biological contexts, potentially leading to novel strategies for managing diseases associated with disrupted metabolic pathways. The advent of advanced protein engineering techniques, such as CRISPR and protein crystallography, has further enhanced our ability to investigate SLC16A4 at a molecular level, paving the way for impactful discoveries in the field of metabolic research.